Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | -9.87% | +68.10% | +1.48% |
Apr. 18 | Top Premarket Decliners | MT |
Apr. 17 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 14.84M | Sales 2025 * | 28.61M | Capitalization | 3.76M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | - | EV / Sales 2024 * | 0.25 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.13 x |
P/E ratio 2024 * |
-4.72
x | P/E ratio 2025 * |
-137
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.16% |
Latest transcript on INVO Bioscience, Inc.
1 day | -9.87% | ||
1 week | +68.10% | ||
Current month | +21.24% | ||
1 month | +34.31% | ||
3 months | +30.48% | ||
6 months | +132.20% | ||
Current year | +1.48% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Shum
CEO | Chief Executive Officer | 55 | 17-10-10 |
Andrea Goren
DFI | Director of Finance/CFO | 56 | 21-06-13 |
Chief Tech/Sci/R&D Officer | - | 20-02-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trent Davis
BRD | Director/Board Member | 56 | 19-12-15 |
Barbara Ryan
BRD | Director/Board Member | 64 | 20-09-13 |
Corporate Secretary | 55 | 08-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.37 | -9.87% | 1,395,750 |
24-04-18 | 1.52 | -16.48% | 5,048,023 |
24-04-17 | 1.82 | +139.47% | 226,638,759 |
24-04-16 | 0.76 | -0.91% | 3,854,086 |
24-04-15 | 0.767 | -5.89% | 24,362 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.48% | 4.17M | |
-2.53% | 183B | |
-3.52% | 105B | |
+5.33% | 51.77B | |
+16.43% | 47.29B | |
-1.73% | 40.2B | |
+5.66% | 27.62B | |
-2.01% | 25.51B | |
+9.84% | 24.73B | |
-1.87% | 24.52B |
- Stock Market
- Equities
- INVO Stock